Ignite Creation Date:
2024-05-06 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05339204
Status:
RECRUITING
Last Update Posted:
2022-04-21
First Post:
2022-04-14
Brief Title:
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
Sponsor:
National Research Center for Hematology Russia
Organization:
National Research Center for Hematology Russia
Organization Data
Organization:
National Research Center for Hematology Russia
Class:
NETWORK
Study ID:
AML-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Research Center for Hematology Russia
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Botkin Hospital | OTHER |
| St Petersburg State Pavlov Medical University | OTHER |
| Federal State Budgetary Institution V A Almazov Federal North-West Medical Research Centre of the Ministry of Health | OTHER |
| Federal Research Clinical Center of Federal Medical Biological Agency Russia | OTHER_GOV |
| Regional Clinical Hospital of Yaroslavl | UNKNOWN |
| Nizhny Novgorod regional clinical hospital named after NASemashko | UNKNOWN |
| Clinical hospital 1 of Sverdlovsk region | UNKNOWN |
| Irkutsk regional clinical hospital winner of the Mark of the Honor award | UNKNOWN |
| The Federal State-Financed Scientific Institution Kirov Research Institute of Hematology and Blood T | OTHER_GOV |